Günter Ditzinger

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Marquard Media International AG publishes magazines and periodicals. It also publishes a range of magazines from lifestyle, special interest, gaming, fitness and electronic entertainment. The company was founded by Jurg Marquard in 1965 and is headquartered in Baar, Switzerland.

Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland.

Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland.

Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland.

Lindt & Sprungli (USA), Inc. manufactures candy and other confectionery products. It offers truffles, boxed chocolates, bars, and European specialties, milk chocolates, dark and white chocolates, and blends. The company was founded in 1925 and is headquartered in Stratham, NH.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany.

PharmaSwiss SA engages in the provision of healthcare solutions. It also offers consulting services. The company was founded on January 24, 2000 and is headquartered in Zug, Switzerland.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Spanset Inter AG functions as an investment holding company. The company was founded in 1966 and is headquartered in Wollerau, Switzerland.

Part of Future Plc, Hotel de la Paix is a 4-star hotel located in Lausanne, Switzerland. The hotel offers charming suites and rooms with views of Lake Geneva, as well as restaurants and bars. Additionally, the hotel provides seminar and reception spaces for conferences and events.

Ridoret Distribution SARL provides carpentry services. It specializes in doors and windows. The firm also provides client consulting. The company was founded on November 16, 1982 and is headquartered in La Rochelle, France.

InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland.

iJet Technologies, Inc. engages in the integrates aircraft operational data, IP communication links and airline ground systems into software solutions. Its data access platform acquires, transforms and makes aircraft data available to applications and analytics, in the air and on the ground. The firm’s solutions begins with the iJet data access platform which includes a data platform onboard each aircraft connected via IP links to an intelligent ground platform. The company was founded by Jan Petter Roed and is headquartered in Seattle, WA.

Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark.

Caveat Holding AG functions as an investment holding Swiss company. The private company is based in Hergiswil, Switzerland.

Twin Dolphins Holding AG engages in the acquisition, holding, management, and sale of participations in companies. It also acquires, administers, and sells real estate properties. The company was founded on April 26, 2013 and is headquartered in Baar, Switzerland.

AntibioTx ApS develops and manufactures pharmaceutical products. The private company is based in Kongens Lyngby, Denmark.

Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The company is based in London, UK.

Turtle Capital Investment Ltd. provides investment services.

Nest AS is an online store based in Oslo, Norway that was founded in 2018. The Norwegian company offers a wide range of trendy fashion, interior, and accessories for women. Nest AS takes pride in providing well-known quality brands such as Part Two, Ella & Iil, Reunion, and Is of Norway, among others. The company's online store is one of the largest in Norway, and customers can shop for their favorite items with ease.